The Value in Cancer Care Consortium (vi3c) is non-profit entity incorporated as a 501c(3) tax-exempt public charity with the mission of improving the value of existing treatments to cancer patients and society through rigorous science. 

Our studies aim to improve access, affordability and sustainability (value) of a cancer therapy by:

● Optimizing the delivery of existing drugs (decreasing frequency, reducing the dosage, enhancing drug absorption)

● Generating evidence supporting the substitution of high-priced drugs for existing mechanistically similar and less costly drugs

● Comparing approved regimens, where the intervention regimen is safer or less costly with similar efficacy